China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · IEX Real-Time Price · USD
0.371
-0.054 (-12.68%)
Mar 28, 2024, 3:59 PM EDT - Market closed

China Pharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2007
Revenue
8.19.6410.8710.9212.3313.2115.5720.3522.1332.81
Upgrade
Revenue Growth (YoY)
-15.95%-11.27%-0.53%-11.41%-6.67%-15.15%-23.49%-8.05%-32.53%-39.81%
Upgrade
Cost of Revenue
8.69.298.919.4410.3610.7412.3518.8919.4733.29
Upgrade
Gross Profit
-0.490.351.951.481.972.473.221.462.67-0.48
Upgrade
Selling, General & Admin
2.963.154.044.645.175.486.36.195.065.69
Upgrade
Research & Development
0.190.320.380.230.170.090.370.962.81.68
Upgrade
Other Operating Expenses
-0.09-0.260.1217.027.0815.584.718.6133.5610.75
Upgrade
Operating Expenses
3.063.214.5321.8912.4221.1511.3715.7641.4318.13
Upgrade
Operating Income
-3.55-2.86-2.58-20.41-10.45-18.68-8.16-14.3-38.76-18.61
Upgrade
Interest Expense / Income
0.430.540.290.320.450.540.851.170.790.35
Upgrade
Other Expense / Income
-0.01-0-0.01-0.03-0.04-0.06-0.13-0.12-0.07-0.01
Upgrade
Pretax Income
-3.97-3.4-2.87-20.7-10.86-19.15-8.87-15.35-39.47-18.95
Upgrade
Income Tax
0000-0.110.120.310.060.081.06
Upgrade
Net Income
-3.97-3.4-2.87-20.7-10.75-19.28-9.18-15.41-39.55-20.01
Upgrade
Shares Outstanding (Basic)
1111111111
Upgrade
Shares Outstanding (Diluted)
11111111--
Upgrade
Shares Change
13.96%5.74%0.10%-------
Upgrade
EPS (Basic)
-3.80-3.70-3.50-24.00-12.50-22.00-10.50-17.50-45.50-23.00
Upgrade
EPS (Diluted)
-3.80-3.70-3.50-24.00-12.50-22.00-10.50-17.50-45.50-23.00
Upgrade
Free Cash Flow
-0.81-0.69-0.910.471.830.72.72.661.02-10.2
Upgrade
Free Cash Flow Per Share
-0.77-0.75-1.040.542.100.813.103.061.18-11.70
Upgrade
Gross Margin
-6.09%3.62%17.97%13.57%16.02%18.68%20.67%7.20%12.05%-1.47%
Upgrade
Operating Margin
-43.79%-29.67%-23.73%-186.82%-84.73%-141.38%-52.38%-70.26%-175.11%-56.72%
Upgrade
Profit Margin
-49.02%-35.26%-26.38%-189.51%-87.18%-145.91%-58.97%-75.70%-178.69%-60.99%
Upgrade
Free Cash Flow Margin
-10.01%-7.13%-8.37%4.32%14.85%5.33%17.36%13.09%4.63%-31.09%
Upgrade
EBITDA
-0.840.230.11-17.45-7.15-15.32-4.95-10.58-36.9-16.99
Upgrade
EBITDA Margin
-10.34%2.39%0.98%-159.75%-57.99%-115.98%-31.77%-51.99%-166.72%-51.77%
Upgrade
Depreciation & Amortization
2.73.092.682.933.263.293.083.61.791.61
Upgrade
EBIT
-3.54-2.86-2.57-20.38-10.41-18.62-8.02-14.18-38.69-18.6
Upgrade
EBIT Margin
-43.66%-29.64%-23.67%-186.57%-84.41%-140.90%-51.54%-69.67%-174.79%-56.69%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).